Clinical Scorecard: Impact of Omicron Variant on Organ Failure Patterns in Severe COVID-19: A Multicenter Comparison with Wild-Type Strain
At a Glance
Category
Detail
Condition
Severe COVID-19 infection caused by SARS-CoV-2 Omicron variant versus Wild-type strain
Key Mechanisms
Differences in organ dysfunction patterns and severity of disease between Omicron and Wild-type strains; organ failure as a key determinant of prognosis
Target Population
Adult patients hospitalized with severe COVID-19 infection in China and prior cohorts
Care Setting
Intensive care units and designated hospitals in multicenter national research centers
Key Highlights
Omicron variant associated with lower hospitalization and mortality rates compared to Wild-type strain but caused a sharp increase in severe cases during the 2022-2023 outbreak in China.
Organ dysfunction patterns differ between Omicron and Wild-type infections, impacting clinical outcomes and prognosis.
Large multicenter retrospective study comparing clinical characteristics, organ failure, and risk factors for severe disease and mortality between Omicron and Wild-type cohorts.
Guideline-Based Recommendations
Diagnosis
Diagnosis of COVID-19 Omicron infection based on clinical symptoms, positive nucleic acid or antigen tests, or elevated COVID-19-specific IgG antibody levels in recovery phase.
Wild-type strain diagnosis confirmed by positive RT-PCR testing during early 2020 pandemic period.
Management
Severe COVID-19 defined by need for high-flow nasal oxygen, noninvasive or invasive mechanical ventilation, or death without respiratory support.
Treatment includes respiratory support modalities and monitoring of organ function using SOFA scores.
Monitoring & Follow-up
Regular assessment of organ dysfunction using SOFA scores on hospital days 1, 3, and 7.
Laboratory monitoring includes blood counts, electrolytes, hepatic and renal function, coagulation, arterial blood gases, inflammatory markers, and cardiac enzymes.
Risks
Risk factors for severe disease and mortality differ between Omicron and Wild-type infections and require further elucidation.
Organ failure is a critical determinant of poor prognosis in COVID-19.
Patient & Prescribing Data
Adult hospitalized patients with severe COVID-19 infection due to Omicron or Wild-type strains.
Respiratory support tailored to severity; monitoring organ dysfunction guides clinical management; vaccination status and comorbidities influence outcomes.
Clinical Best Practices
Implement symptom-driven testing and diagnosis during large-scale Omicron outbreaks when community screening is limited.
Use SOFA scoring to monitor organ dysfunction progression and guide treatment decisions.
Recognize differences in clinical characteristics and organ failure patterns between Omicron and Wild-type infections to optimize patient care.
Prioritize resource allocation during surges given rapid increases in severe cases with Omicron variant.
Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.
